Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

PHASE4CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

May 19, 2010

Primary Completion Date

November 29, 2010

Study Completion Date

November 29, 2010

Conditions
ADHD Specifically With Executive Function Impairment
Interventions
DRUG

SPD489

1 capsule per day (30, 50 or 70 mg), daily throughout the double-blind treatment period (10 weeks)

OTHER

Placebo

1 capsule per day, daily throughout the double-blind treatment period (10 weeks)

Trial Locations (39)

10016

Mental Health and Addictive Disorders Research Program, New York

10549

Bioscience Research, LLC, Mount Kisco

20170

Neuroscience, Inc, Herndon

20852

Mark Hertzman MD, PC, Rockville

27609

Richard H. Weisler, MD, Pa & Associates, Raleigh

27707

Triangle Neuropsychiatry, Durham

30060

Northwest Behavioral Research Center, Marietta

30308

Atlanta Center For Medical Research, Atlanta

32250

Dr. George Joseph, MD and Associates PA, Jacksonville Beach

32751

Florida Clinical Research Center, LLC, Maitland

32806

CNS Healthcare, Orlando

33407

Janus Center For Psychiatric Research, West Palm Beach

33912

Gulfcoast Clinical Research Center, Fort Myers

34208

Florida Clinical Research Center, LLC, Bradenton

42003

Four Rivers Clinical Research, Paducah

48307

Rochester Center for Behavioral Medicine, Rochester Hills

49686

The Behavioral Medicine Clinic of NW Michigan, PC, Traverse City

53562

Dean Foundation for Health, Research and Education, Middleton

60048

Capstone Clinical Research, Libertyville

60563

AMR-BABER Research Inc., Naperville

63301

Midwest Research Group, Saint Charles

66211

Psychiatric Associates, Overland Park

Vince and Associates Clinical Research, Inc., Overland Park

72205

Clinical Study Centers, LLC, Little Rock

77007

Bayou City Research, Ltd., Houston

77090

Red Oak Psychiatry Associates P.A., Houston

78756

FutureSearch Trials, LP, Austin

79423

John M. Turnbow, MD, PA, Lubbock

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

90274

Peninsula Research Assoc, Inc, Rolling Hills Estates

92108

PCSD Feighner Research, San Diego

97210

Oregon Center for Clinical Investigations, Inc., Portland

97301

Occi, Inc (Oregon Center For Clinical Investigations, Inc.), Salem

98033

Eastside Therapeutic Resource, Kirkland

98104

Summit Research Network, LLC, Seattle

99202

Rockwood Clinic, Spokane

05401

Vermont Clinical Study Center, Burlington

05091

Neuropsychiatric Associates, Woodstock

Unknown

Center for Emotional Fitness, Cherry Hill

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY